Apoptosis induced by neodjuvant chemotherapy in breast cancer (2006)
- Authors:
- USP affiliated authors: ANDRADE, JURANDYR MOREIRA DE - FMRP ; REIS, FRANCISCO JOSÉ CÂNDIDO DOS - FMRP ; SILVA, ALFREDO RIBEIRO DA - FMRP
- Unidade: FMRP
- DOI: 10.1080/00313020500465315
- Subjects: NEOPLASIAS MAMÁRIAS; QUIMIOTERAPIA
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
TIEZZI, Daniel Guimarães et al. Apoptosis induced by neodjuvant chemotherapy in breast cancer. Pathology, v. 38, n. 1, p. 1-7, 2006Tradução . . Disponível em: https://doi.org/10.1080/00313020500465315. Acesso em: 06 maio 2024. -
APA
Tiezzi, D. G., Andrade, J. M. de, Reis, F. J. C. dos, Marana, H. R. C., Ribeiro-Silva, A., Tiezzi, M. G., & Pereira, A. P. (2006). Apoptosis induced by neodjuvant chemotherapy in breast cancer. Pathology, 38( 1), 1-7. doi:10.1080/00313020500465315 -
NLM
Tiezzi DG, Andrade JM de, Reis FJC dos, Marana HRC, Ribeiro-Silva A, Tiezzi MG, Pereira AP. Apoptosis induced by neodjuvant chemotherapy in breast cancer [Internet]. Pathology. 2006 ; 38( 1): 1-7.[citado 2024 maio 06 ] Available from: https://doi.org/10.1080/00313020500465315 -
Vancouver
Tiezzi DG, Andrade JM de, Reis FJC dos, Marana HRC, Ribeiro-Silva A, Tiezzi MG, Pereira AP. Apoptosis induced by neodjuvant chemotherapy in breast cancer [Internet]. Pathology. 2006 ; 38( 1): 1-7.[citado 2024 maio 06 ] Available from: https://doi.org/10.1080/00313020500465315 - Induction of apoptosis predicts response to neoadjuvant chemotherapy in locally advanced breast cancer
- HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin
- HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination
- Induction of apoptosis predicts the response to the neoadjuvant chemotherapy in locally advanced breast cancer
- Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases with review of the literature
- HER2 overexpression predicts survival in stage II and III of breast cancer patients treated with neoadjuvant docetaxel plus epirubicin
- Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases and review of the literature
- HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin
- Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases
- Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer
Informações sobre o DOI: 10.1080/00313020500465315 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
